The Valley Desk

EditorialNeuro-oncologyPublished

Phase II trials in the era of glioblastoma immunotherapy: New mechanisms of action, familiar challenges in trial design and tumor response assessment

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Editorial
Venue
Neuro-oncology
Published
Subject terms
Humans; Glioblastoma; Receptors, Interleukin-4; Immunoconjugates; Immunotherapy
PubMed ID
36789741
PubMed Central ID
PMC10237420
Added to directory
Source checked

Report a correction or request removal